{
    "hands_on_practices": [
        {
            "introduction": "Managing necrotizing enterocolitis (NEC) demands a deep understanding of the delicate balance between providing adequate nutrition for growth and protecting the vulnerable preterm intestine. This practice focuses on a key iatrogenic risk: the osmolarity of enteral feeds. You will apply fundamental principles of physical chemistry to a common clinical scenario—the fortification of human milk—to appreciate how a seemingly simple intervention can create physiologically significant osmotic stress, a primary trigger in the pathophysiology of NEC . This exercise will strengthen your ability to connect basic science concepts to preventative clinical strategies.",
            "id": "5172990",
            "problem": "A preterm newborn at risk for necrotizing enterocolitis (NEC) is prescribed expressed human milk with a measured base osmolarity of $300$ milliosmoles per liter (mOsm/L). A standardized powdered human milk fortifier, when added at the manufacturer’s recommended dose, contributes an increment of $120$ mOsm/L to the final mixture’s osmolarity. Assume the fortifier’s added volume is negligible compared with the milk volume, so that the mixture volume is effectively unchanged and the manufacturer’s reported increment can be interpreted as an additive increase in the final osmolarity. Using the fundamental definition that osmolarity is the number of osmoles per liter of solution, calculate the final osmolarity of the fortified feed. Express the final answer in milliosmoles per liter (mOsm/L) as an exact number; no rounding is required. Then, starting from first principles (osmotic pressure and fluid movement across the intestinal mucosa), discuss whether this calculated osmolarity exceeds commonly cited hyperosmolar thresholds associated with higher NEC risk in preterm infants, and justify the physiological reasoning without relying on shortcut formulas.",
            "solution": "The problem consists of two parts: a calculation of the final osmolarity and a physiological discussion based on first principles.\n\n**Part 1: Calculation of Final Osmolarity**\n\nThe osmolarity of a solution is defined as the total number of moles of solute particles (osmoles) per liter of solution. The unit given is milliosmoles per liter (mOsm/L).\n\nLet $C_{milk}$ be the initial osmolarity of the expressed human milk.\n$$C_{milk} = 300 \\, \\text{mOsm/L}$$\nLet $\\Delta C_{fortifier}$ be the increment in osmolarity contributed by the fortifier.\n$$\\Delta C_{fortifier} = 120 \\, \\text{mOsm/L}$$\n\nThe problem states that the volume of the powdered fortifier is negligible, meaning the final volume of the solution is considered to be the same as the initial volume of the milk. Under this condition, the osmoles from the milk and the fortifier are combined in the same final volume. Therefore, the final osmolarity, $C_{final}$, is the direct sum of the initial milk osmolarity and the osmolarity increment from the fortifier.\n\n$$C_{final} = C_{milk} + \\Delta C_{fortifier}$$\nSubstituting the given values:\n$$C_{final} = 300 \\, \\text{mOsm/L} + 120 \\, \\text{mOsm/L} = 420 \\, \\text{mOsm/L}$$\nThe final osmolarity of the fortified feed is $420$ mOsm/L.\n\n**Part 2: Physiological Discussion of Hyperosmolarity and NEC Risk**\n\nThe discussion will proceed from the fundamental principles of osmosis and fluid dynamics across a semipermeable membrane, as applied to the preterm infant's intestine.\n\n**1. First Principles of Osmosis and Osmotic Pressure:**\nOsmosis is the net movement of solvent molecules (in this case, water) across a semipermeable membrane from a region of lower solute concentration to a region of higher solute concentration. This movement is driven by a difference in water potential, which creates an osmotic pressure gradient. The osmotic pressure, $\\Pi$, of an ideal solution is given by the van 't Hoff equation: $\\Pi = iMRT$, where $iM$ is the osmolarity of the solution ($C$), $R$ is the ideal gas constant, and $T$ is the absolute temperature. The crucial principle here is that osmotic pressure is directly proportional to the solution's osmolarity: $\\Pi \\propto C$. Therefore, a higher osmolarity solution exerts a higher osmotic pressure.\n\n**2. The Intestinal Mucosa as a Semipermeable Membrane:**\nThe gastrointestinal tract is lined by an epithelial layer, the intestinal mucosa. This layer functions as a semipermeable membrane, separating the contents of the intestinal lumen from the body's internal environment (interstitial fluid and blood plasma). The osmolarity of human plasma and interstitial fluid is homeostatically maintained within a narrow range, typically around $285$ to $295$ mOsm/L.\n\n**3. Application to the Preterm Infant:**\nThe unfortified human milk, with an osmolarity of $300$ mOsm/L, is nearly isosmolar with the infant's plasma. This creates a minimal osmotic gradient across the intestinal mucosa, resulting in little to no net water flux, which is well-tolerated.\n\nThe calculated final osmolarity of the fortified feed is $C_{final} = 420$ mOsm/L. This solution is significantly hyperosmolar relative to the infant's plasma osmolarity ($C_{plasma} \\approx 290$ mOsm/L). When this hyperosmolar feed enters the lumen of the small intestine, it establishes a substantial osmotic gradient across the mucosal membrane. The osmolarity in the lumen ($C_{lumen} = 420$ mOsm/L) is much greater than that of the surrounding tissues ($C_{tissue} \\approx 290$ mOsm/L).\n\nAccording to the principles of osmosis, this gradient drives the net movement of water from the region of lower osmolarity (the intestinal cells and submucosal tissue) into the region of higher osmolarity (the intestinal lumen).\n\n**4. Pathophysiological Consequences and a Priori Justification for Increased NEC Risk:**\nThis osmotically-induced fluid shift has severe consequences, particularly in the vulnerable preterm infant's gut:\n- **Mucosal Cell Injury:** The efflux of water from the epithelial cells leads to cellular dehydration, shrinkage, and functional impairment. This direct damage compromises the integrity of the mucosal barrier.\n- **Compromised Perfusion:** The accumulation of water in the intestinal lumen can cause luminal distension. This distension increases intramural pressure within the bowel wall, which can compress the delicate submucosal capillaries and reduce mucosal blood flow (perfusion), leading to localized ischemia. Ischemic tissue is highly susceptible to further injury.\n- **Initiation of NEC Cascade:** The preterm infant's gut is characterized by immaturity, including poor motility, underdeveloped digestive and absorptive functions, and a fragile, \"leaky\" mucosal barrier. The initial osmotic injury exacerbates this baseline vulnerability. Damage to the mucosal barrier allows luminal bacteria and their endotoxins to translocate across the epithelium into the bowel wall and systemic circulation. This translocation triggers an uncontrolled inflammatory cascade, leading to thrombosis, tissue necrosis, and intramural gas formation (pneumatosis intestinalis), which are the pathological hallmarks of necrotizing enterocolitis.\n\n**5. Comparison with Hyperosmolar Thresholds:**\nClinical bodies and researchers have proposed safety thresholds for the osmolarity of infant feeds. While there is no single, universally agreed-upon value, a commonly cited upper limit of caution is in the range of $400$ to $450$ mOsm/L (or mOsm/kg H₂O, which is numerically similar for dilute aqueous solutions). The calculated value of $420$ mOsm/L is within or exceeds this cautionary range. Therefore, based on first principles of osmotic fluid shifts and the known vulnerabilities of the preterm gut, a feed with this osmolarity is justifiably considered to pose an elevated risk for developing necrotizing enterocolitis. It creates biophysical conditions that are known to initiate the cascade of mucosal injury fundamental to the disease's pathogenesis.",
            "answer": "$$\n\\boxed{420}\n$$"
        },
        {
            "introduction": "When an infant presents with suspected NEC, swift and accurate assessment is critical for determining prognosis and guiding immediate management. This exercise transitions from prevention to acute diagnosis by focusing on the interpretation of key laboratory data. By analyzing a typical arterial blood gas and serum lactate level from a critically ill neonate, you will practice identifying complex acid-base disturbances and understanding the profound prognostic implications of metabolic acidosis and hyperlactatemia . Mastering this skill is essential for recognizing the severity of intestinal ischemia and systemic shock, enabling you to make timely and life-saving clinical decisions.",
            "id": "5173014",
            "problem": "A preterm newborn of $28$ weeks gestation on day $10$ of life presents with abdominal distension, increased gastric residuals, lethargy, and temperature instability. The examination shows a distended, tender abdomen with mottled skin over the flanks. Vital signs: heart rate $180$ beats per minute, mean arterial pressure $32$ mmHg, respiratory rate $60$ breaths per minute with intermittent apnea, oxygen saturation $92\\%$ on continuous positive airway pressure. An abdominal radiograph shows dilated bowel loops with possible pneumatosis intestinalis. Laboratory evaluation reveals a complete blood count with thrombocytopenia and a C-reactive protein elevation. An arterial blood gas (ABG) obtained during this evaluation shows: $pH=7.25$, arterial partial pressure of carbon dioxide (PaCO$_2$) $=38$ mmHg, bicarbonate (HCO$_3^-$) $=16$ mEq/L. Serum lactate is $5.8$ mmol/L.\n\nUsing the Henderson–Hasselbalch relationship between $pH$, buffer base (HCO$_3^-$), and PaCO$_2$, and the well-established patterns of respiratory compensation for primary metabolic disturbances, determine the acid–base disorder and infer the prognostic implication of the elevated lactate in the context of suspected necrotizing enterocolitis (NEC). Which of the following is the most accurate interpretation?\n\nA. The data indicate a primary metabolic acidosis with inadequate respiratory compensation (a superimposed respiratory acidosis); the elevated lactate reflects tissue hypoperfusion from intestinal ischemia and is associated with a higher likelihood of transmural necrosis, need for surgical intervention, and increased mortality, warranting urgent escalation and surgical consultation.\n\nB. The data indicate a primary respiratory acidosis with appropriate renal compensation; the elevated lactate in neonates is nonspecific and not prognostic in NEC, so observation and continuation of enteral feeds are appropriate.\n\nC. The data indicate a primary metabolic acidosis with fully appropriate respiratory compensation; the elevated lactate is most consistent with hepatic immaturity rather than hypoperfusion and does not inform severity or the need for surgery in NEC.\n\nD. The data indicate a mixed metabolic acidosis and respiratory alkalosis due to sepsis-associated hyperventilation; the elevated lactate suggests high cardiac output and preserved tissue perfusion, predicting a lower risk of bowel necrosis.",
            "solution": "The solution requires a two-part analysis: first, interpreting the acid-base status from the ABG values, and second, interpreting the prognostic significance of the serum lactate in the clinical context of NEC.\n\n**Part 1: Acid–Base Disorder Analysis**\n\n1.  **Consistency Check with Henderson–Hasselbalch Equation**: The relationship is given by $pH = pK_a + \\log_{10} \\left( \\frac{[HCO_3^-]}{\\alpha \\times PaCO_2} \\right)$, where the $pK_a$ for the bicarbonate buffer system is approximately $6.1$ and the solubility coefficient $\\alpha$ for CO$_2$ in plasma is $0.03$ mmol/L/mmHg.\n    Given: $pH = 7.25$, $PaCO_2 = 38$ mmHg, $HCO_3^- = 16$ mEq/L.\n    Calculating the $pH$ from the given $PaCO_2$ and $HCO_3^-$:\n    $$pH = 6.1 + \\log_{10} \\left( \\frac{16}{0.03 \\times 38} \\right)$$\n    $$pH = 6.1 + \\log_{10} \\left( \\frac{16}{1.14} \\right)$$\n    $$pH = 6.1 + \\log_{10}(14.035)$$\n    $$pH = 6.1 + 1.147 \\approx 7.247$$\n    The calculated $pH$ of $\\approx 7.25$ matches the provided value, confirming the internal consistency of the ABG data.\n\n2.  **Systematic ABG Interpretation**:\n    a.  **Assess $pH$**: The measured $pH$ is $7.25$. The normal range for arterial $pH$ is $7.35$ to $7.45$. Since $7.25 < 7.35$, the patient has an **acidemia**.\n    b.  **Identify the Primary Disturbance**: We examine the metabolic ($HCO_3^-$) and respiratory ($PaCO_2$) components to find the cause of the acidemia.\n        -   The $HCO_3^-$ is $16$ mEq/L. The normal range is approximately $22$ to $26$ mEq/L. A low bicarbonate level causes a **metabolic acidosis**.\n        -   The $PaCO_2$ is $38$ mmHg. The normal range is $35$ to $45$ mmHg. A value of $38$ mmHg is within the normal range and does not suggest a primary respiratory cause for the acidemia.\n        -   Therefore, the primary disturbance is a **metabolic acidosis**.\n\n    c.  **Evaluate for Compensation**: In a primary metabolic acidosis, the physiological response is respiratory compensation, which involves increasing ventilation to lower the $PaCO_2$. We must determine if the degree of compensation is appropriate. Winter's formula predicts the expected $PaCO_2$:\n        $$ \\text{Expected } PaCO_2 = (1.5 \\times [HCO_3^-]) + 8 \\pm 2 $$\n        $$ \\text{Expected } PaCO_2 = (1.5 \\times 16) + 8 \\pm 2 $$\n        $$ \\text{Expected } PaCO_2 = 24 + 8 \\pm 2 $$\n        $$ \\text{Expected } PaCO_2 = 32 \\pm 2 $$\n        The expected range for appropriate respiratory compensation is a $PaCO_2$ between $30$ and $34$ mmHg. The patient's actual $PaCO_2$ is $38$ mmHg.\n        Since the actual $PaCO_2$ of $38$ mmHg is higher than the expected compensatory range of $30-34$ mmHg, the respiratory compensation is inadequate. This indicates the presence of a superimposed **primary respiratory acidosis**. The infant is failing to hyperventilate appropriately, likely due to sepsis-induced respiratory muscle fatigue, central nervous system depression, and the observed intermittent apnea.\n    \n    d. **Anion Gap Calculation**: A high anion gap metabolic acidosis is expected. The anion gap (AG) is calculated as $AG = [Na^+] - ([Cl^-] + [HCO_3^-])$. Although sodium and chloride are not provided, the elevated lactate of $5.8$ mmol/L is the unmeasured anion responsible for the low bicarbonate and thus confirms a high anion gap metabolic acidosis.\n\n    **Conclusion for Part 1**: The infant has a **mixed acid-base disorder**, specifically a **primary high anion gap metabolic acidosis with a superimposed respiratory acidosis**.\n\n**Part 2: Prognostic Implication of Elevated Lactate in NEC**\n\nThe serum lactate is $5.8$ mmol/L, which is significantly elevated (normal $<2$ mmol/L). In the context of suspected NEC, this finding is of grave prognostic importance.\n-   **Pathophysiology**: NEC is characterized by intestinal inflammation, ischemia, and necrosis. Ischemic bowel tissue switches to anaerobic glycolysis, leading to massive production of lactic acid. This lactate is released into the systemic circulation. The patient's clinical signs of shock (tachycardia with HR $180$, severe hypotension with MAP $32$ mmHg, poor perfusion with mottled skin) indicate systemic hypoperfusion, which both adds to lactate production from other poorly perfused tissues and impairs lactate clearance by the liver.\n-   **Prognosis**: Elevated serum lactate in NEC is a robust and well-validated biomarker of disease severity. It strongly correlates with:\n    -   The presence and extent of intestinal necrosis, particularly **transmural necrosis** (death of the full thickness of the bowel wall).\n    -   The need for **surgical intervention** (laparotomy to resect necrotic bowel).\n    -   Increased risk of **mortality**.\n\nA lactate level of $5.8$ mmol/L in this clinical scenario signifies severe tissue hypoperfusion and ischemia, primarily from the gut, and is a harbinger of a poor outcome without aggressive intervention. This warrants urgent escalation of care, including aggressive resuscitation and immediate surgical consultation.\n\n### Evaluation of Options\n\n**A. The data indicate a primary metabolic acidosis with inadequate respiratory compensation (a superimposed respiratory acidosis); the elevated lactate reflects tissue hypoperfusion from intestinal ischemia and is associated with a higher likelihood of transmural necrosis, need for surgical intervention, and increased mortality, warranting urgent escalation and surgical consultation.**\n-   **Acid-base analysis**: \"primary metabolic acidosis with inadequate respiratory compensation (a superimposed respiratory acidosis)\" is precisely what was derived using Winter's formula. This is correct.\n-   **Lactate interpretation**: The interpretation of lactate as a marker of tissue hypoperfusion from ischemia, predicting transmural necrosis, need for surgery, and increased mortality is clinically and scientifically accurate.\n-   **Action**: The recommended action of urgent escalation and surgical consultation is the standard of care for this severe presentation.\n-   **Verdict**: **Correct**.\n\n**B. The data indicate a primary respiratory acidosis with appropriate renal compensation; the elevated lactate in neonates is nonspecific and not prognostic in NEC, so observation and continuation of enteral feeds are appropriate.**\n-   **Acid-base analysis**: \"primary respiratory acidosis\" is incorrect. The primary disorder is metabolic acidosis. \"appropriate renal compensation\" would involve an increase in $HCO_3^-$, but it is low. This analysis is fundamentally flawed.\n-   **Lactate interpretation**: \"nonspecific and not prognostic\" is false. Lactate is a key prognostic marker in NEC.\n-   **Action**: \"observation and continuation of enteral feeds\" is dangerous medical malpractice in this context.\n-   **Verdict**: **Incorrect**.\n\n**C. The data indicate a primary metabolic acidosis with fully appropriate respiratory compensation; the elevated lactate is most consistent with hepatic immaturity rather than hypoperfusion and does not inform severity or the need for surgery in NEC.**\n-   **Acid-base analysis**: \"fully appropriate respiratory compensation\" is incorrect. As calculated, the compensation is inadequate.\n-   **Lactate interpretation**: While hepatic immaturity contributes to baseline lactate metabolism in preterm infants, attributing a level of $5.8$ mmol/L in a state of shock to immaturity is a gross misinterpretation. The primary cause is ischemic overproduction. The claim that lactate \"does not inform severity\" is false.\n-   **Verdict**: **Incorrect**.\n\n**D. The data indicate a mixed metabolic acidosis and respiratory alkalosis due to sepsis-associated hyperventilation; the elevated lactate suggests high cardiac output and preserved tissue perfusion, predicting a lower risk of bowel necrosis.**\n-   **Acid-base analysis**: \"mixed metabolic acidosis and respiratory alkalosis\" is incorrect. The patient has a respiratory acidosis, not alkalosis. The actual $PaCO_2$ is higher than the compensatory target.\n-   **Lactate interpretation**: The interpretation of preserved tissue perfusion is directly contradicted by the clinical signs of shock (hypotension, mottling). Therefore, predicting a lower risk is incorrect.\n-   **Verdict**: **Incorrect**.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Effective treatment is as crucial as accurate diagnosis. This final practice delves into the therapeutic management of NEC, specifically the administration of antibiotics like gentamicin. Preterm infants exhibit significant variability in drug metabolism and clearance, making standardized dosing a challenge and creating risks of both antibiotic toxicity and therapeutic failure. This problem provides a hands-on application of clinical pharmacokinetics, tasking you with using therapeutic drug monitoring (TDM) data to calculate a patient-specific dosing interval . This exercise simulates a core competency of neonatal critical care: tailoring pharmacotherapy to individual physiology to maximize efficacy and ensure patient safety.",
            "id": "5173041",
            "problem": "A $900$ gram preterm newborn with suspected necrotizing enterocolitis is initiated on empiric ampicillin plus gentamicin. The gentamicin regimen is $5$ $\\mathrm{mg/kg}$ administered intravenously every $48$ hours, consistent with extended-interval dosing in very low birth weight infants. The infant’s body weight is $0.9$ $\\mathrm{kg}$ and the serum creatinine is $1.3$ $\\mathrm{mg/dL}$, reflecting reduced renal clearance typical of extremely preterm neonates. Therapeutic Drug Monitoring (TDM) is performed after the first dose: a gentamicin peak concentration measured $0.5$ hours after the infusion is $9$ $\\mathrm{mg/L}$, and a trough concentration measured immediately prior to the next scheduled dose at $48$ hours is $2.5$ $\\mathrm{mg/L}$. Target gentamicin concentrations are a peak of $8$–$10$ $\\mathrm{mg/L}$ and a trough less than $1$ $\\mathrm{mg/L}$.\n\nAssume a one-compartment model with first-order elimination and negligible infusion time relative to the elimination phase. Assume the volume of distribution remains constant across doses. Using fundamental pharmacokinetic principles and the provided TDM data, determine the adjusted dosing interval (in hours) that would most closely achieve a trough of $1$ $\\mathrm{mg/L}$ before the next dose while maintaining the same dose of $5$ $\\mathrm{mg/kg}$. Express your final answer in hours and round your answer to four significant figures.",
            "solution": "The solution requires determining a new dosing interval, $\\tau'$, based on a one-compartment model with first-order elimination. The concentration of the drug, $C$, at any time $t$ after a given starting concentration $C_{start}$ is described by the equation:\n$$\nC(t) = C_{start} \\exp(-k_e \\Delta t)\n$$\nwhere $k_e$ is the first-order elimination rate constant and $\\Delta t$ is the elapsed time.\n\nFirst, we must calculate the patient's elimination rate constant, $k_e$, using the provided therapeutic drug monitoring (TDM) data. We have two concentration-time points on the elimination curve:\n$1$. The peak concentration, $C_{\\text{peak}} = 9$ $\\mathrm{mg/L}$, measured at time $t_{\\text{peak}} = 0.5$ hours after the infusion.\n$2$. The trough concentration, $C_{\\text{trough}} = 2.5$ $\\mathrm{mg/L}$, measured at time $\\tau = 48$ hours, immediately before the next dose.\n\nThe time interval, $\\Delta t$, between the peak and trough measurements is:\n$$\n\\Delta t = \\tau - t_{\\text{peak}} = 48 \\text{ h} - 0.5 \\text{ h} = 47.5 \\text{ h}\n$$\nWe can relate the peak and trough concentrations using the first-order elimination equation, with $C_{\\text{peak}}$ as the starting concentration for this interval:\n$$\nC_{\\text{trough}} = C_{\\text{peak}} \\exp(-k_e (\\tau - t_{\\text{peak}}))\n$$\nPlugging in the known values:\n$$\n2.5 \\frac{\\mathrm{mg}}{\\mathrm{L}} = 9 \\frac{\\mathrm{mg}}{\\mathrm{L}} \\exp(-k_e (47.5 \\text{ h}))\n$$\nWe solve for $k_e$. First, we take the natural logarithm of both sides:\n$$\n\\ln\\left(\\frac{2.5}{9}\\right) = -k_e (47.5 \\text{ h})\n$$\n$$\nk_e = -\\frac{1}{47.5 \\text{ h}} \\ln\\left(\\frac{2.5}{9}\\right)\n$$\nThis provides the elimination rate constant for this specific patient.\n\nThe objective is to find a new dosing interval, $\\tau'$, that achieves a target trough concentration, $C_{\\text{trough,target}} = 1$ $\\mathrm{mg/L}$. The problem specifies that the dose of $5$ $\\mathrm{mg/kg}$ remains unchanged. Since the volume of distribution, $V_d$, is also assumed to be constant, the peak concentration achieved after each dose will remain the same. Therefore, we use $C_{\\text{peak}} = 9$ $\\mathrm{mg/L}$ for the adjusted regimen.\n\nWe set up the same elimination equation for the new target conditions. The time elapsed between the peak measurement and the new trough measurement will be $\\tau' - t_{\\text{peak}}$.\n$$\nC_{\\text{trough,target}} = C_{\\text{peak}} \\exp(-k_e (\\tau' - t_{\\text{peak}}))\n$$\nWe can now solve for the new interval $\\tau'$.\n$$\n\\ln\\left(\\frac{C_{\\text{trough,target}}}{C_{\\text{peak}}}\\right) = -k_e (\\tau' - t_{\\text{peak}})\n$$\n$$\n\\tau' - t_{\\text{peak}} = -\\frac{1}{k_e} \\ln\\left(\\frac{C_{\\text{trough,target}}}{C_{\\text{peak}}}\\right)\n$$\nSubstituting the expression for $k_e$ we derived earlier:\n$$\n\\tau' - t_{\\text{peak}} = -\\left( -\\frac{47.5 \\text{ h}}{\\ln\\left(\\frac{2.5}{9}\\right)} \\right) \\ln\\left(\\frac{C_{\\text{trough,target}}}{C_{\\text{peak}}}\\right)\n$$\n$$\n\\tau' - t_{\\text{peak}} = (47.5 \\text{ h}) \\frac{\\ln\\left(\\frac{C_{\\text{trough,target}}}{C_{\\text{peak}}}\\right)}{\\ln\\left(\\frac{C_{\\text{trough}}}{C_{\\text{peak}}}\\right)}\n$$\nUsing the property $\\ln(a/b) = -\\ln(b/a)$:\n$$\n\\tau' - t_{\\text{peak}} = (47.5 \\text{ h}) \\frac{-\\ln\\left(\\frac{C_{\\text{peak}}}{C_{\\text{trough,target}}}\\right)}{-\\ln\\left(\\frac{C_{\\text{peak}}}{C_{\\text{trough}}}\\right)} = (47.5 \\text{ h}) \\frac{\\ln\\left(\\frac{C_{\\text{peak}}}{C_{\\text{trough,target}}}\\right)}{\\ln\\left(\\frac{C_{\\text{peak}}}{C_{\\text{trough}}}\\right)}\n$$\nNow, we substitute the numerical values:\n$C_{\\text{peak}} = 9$ $\\mathrm{mg/L}$\n$C_{\\text{trough}} = 2.5$ $\\mathrm{mg/L}$\n$C_{\\text{trough,target}} = 1$ $\\mathrm{mg/L}$\n$$\n\\tau' - 0.5 \\text{ h} = (47.5 \\text{ h}) \\frac{\\ln\\left(\\frac{9}{1}\\right)}{\\ln\\left(\\frac{9}{2.5}\\right)}\n$$\n$$\n\\tau' - 0.5 \\text{ h} = (47.5 \\text{ h}) \\frac{\\ln(9)}{\\ln(3.6)}\n$$\nCalculating the values of the logarithms:\n$\\ln(9) \\approx 2.197224577$\n$\\ln(3.6) \\approx 1.280933845$\n$$\n\\tau' - 0.5 \\text{ h} \\approx (47.5 \\text{ h}) \\frac{2.197224577}{1.280933845} \\approx (47.5 \\text{ h}) (1.7153235)\n$$\n$$\n\\tau' - 0.5 \\text{ h} \\approx 81.477866 \\text{ h}\n$$\nFinally, we solve for $\\tau'$:\n$$\n\\tau' \\approx 81.477866 \\text{ h} + 0.5 \\text{ h} = 81.977866 \\text{ h}\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\tau' \\approx 81.98 \\text{ h}\n$$\nThis new dosing interval of approximately $82$ hours would allow the trough concentration to fall to the target of $1$ $\\mathrm{mg/L}$ while maintaining the therapeutic peak concentration.",
            "answer": "$$\\boxed{81.98}$$"
        }
    ]
}